Abpro Holdings (ABPO) Cash from Operations (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Cash from Operations came in at 2080000.0 in Q1 2026, down 38.39% YoY from 3376069.11 in Q1 2025, and down 235.48% on a QoQ basis from 620000.0 in Q4 2025.
Abpro Holdings (ABPO) Cash from Operations (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Cash from Operations data on file, last reported at 2080000.0 in Q1 2026.
- Quarterly Cash from Operations fell 38.39% year-over-year to 2080000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6583000.0 (up 14.34% YoY) and the FY2025 annual result came in at 6006000.0, up 33.49% from the prior year.
- Cash from Operations fell to 2080000.0 in Q1 2026, from 620000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 35541.0 in Q2 2022 to a low of 5895438.0 in Q4 2023.
- A 5-year average of 1511939.0 and a median of 1279559.0 in 2023 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 89.52% in 2023, down 4502.18% in 2023.
- Tracing ABPO's Cash from Operations over 5 years: stood at 128101.0 in 2022, then slumped by 4502.18% to 5895438.0 in 2023, then jumped by 35.29% to 3815000.0 in 2024, then surged by 83.75% to 620000.0 in 2025, then tumbled by 235.48% to 2080000.0 in 2026.
- The last three Cash from Operations figures came in at 2080000.0 (Q1 2026), 620000.0 (Q4 2025), and 2281000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.08 Mn |
| Mar 31, 2026 | -2.08 Mn |
| Dec 31, 2025 | -620,000.00 |
| Dec 31, 2025 | -620,000.00 |
| Sep 30, 2025 | -2.28 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -3.82 Mn |
| Dec 31, 2024 | -3.82 Mn |
| Sep 30, 2024 | -997,000.00 |
| Sep 30, 2024 | -997,000.00 |
| Jun 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Mar 31, 2024 | -2.85 Mn |
| Mar 31, 2024 | -2.85 Mn |
| Dec 31, 2023 | -5.90 Mn |
| Dec 31, 2023 | -5.90 Mn |